GLP-1 discovery may offer even better appetite suppression than Ozempic See more of our coverage in your search results
1 "We know there are people who are interested in addressing their weight but have been waiting on the sidelines for a medicine that was right for them
It is important to understand these potential risks, as they can lead to gastrointestinal effects, cardiovascular complications, and central nervous system problems
Vincent MA, Barrett EJ, Lindner JR, Clark MG, Rattigan S
It should not be described as risk-free or FDA-approved, but it should not be equated with anonymous online research-chemical sales either
The trial was not designed to separate these contributions